,,ii #aaeth ,,congress #b;d ,session ,s4 #bgfi ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,april #bf1 #bjah,mr4 ,heller 7for himself1 ,mr4 ,menendez1 and ,mr4 ,isakson7 introduced the following bill2 which was read twice and referred to the ,committee on ,finance ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to provide for an action plan on recommendations for changes under ,medicare and ,medicaid to prevent opioids addictions and enhance access to medication-assisted treatment1 and for other purposes4 #a4 ,action plan on recommendations for changes under ,medicare and ,medicaid to prevent opioids addictions and enhance access to medication-assisted treatment 7a7 ,in general ,not later than ,january #a1 #bjai1 the ,secretary of ,health and ,human ,services 7in this section referred to as the ,secretary71 in collaboration with the ,pain ,management ,best ,practices ,inter-,agency ,task ,force convened under section #aja7;b7 of the ,comprehensive ,addiction and ,recovery ,act of #bjaf 7,public ,law #aad-aih71 shall develop an action plan that provides recommendations described in subsection 7b74 7b7 ,action plan components ,recommendations provided under the action plan under subsection 7a7 shall include recommendations on the following3 7#a7 ,recommendations on changes to the ,medicare program under title ,,xviii of the ,social ,security ,act and the ,medicaid program under title ,,xix of such ,act that would enhance coverage and reimbursement under such programs of all medication-assisted treatment approved by the ,food and ,drug ,administration for the treatment of opioid addiction and other therapies that manage chronic and acute pain and treat and minimize risk of opioid addiction1 including recommendations on changes to the ,medicare prospective payment system for hospital inpatient department services under section #ahhf7;d7 of such ,act 7#db ,u4,s4,c4 #acieww7d77 and the ,medicare prospective payment system for hospital outpatient department services under section #ahcc7t7 of such ,act 7#db ,u4,s4,c4 #aciel7t77 that would allow for separate reimbursement for such therapies to encourage development and adoption of such therapies1 if medically appropriate4 7#b7 ,recommendations for payment and service delivery models to be tested by the ,center for ,medicare and ,medicaid ,innovation and other federally authorized demonstration projects1 including value-based models1 that may encourage the use of appropriate medication-assisted treatment approved by the ,food and ,drug ,administration for the treatment of opioid addiction and other therapies that manage chronic and acute pain and treat and minimize risk of opioid addiction4 7#c7 ,recommendations for data collection that can facilitate research and policy making regarding prevention of opioid addiction and coverage and reimbursement under the ,medicare program and the ,medicaid program of appropriate opioid addiction treatments4 7#d7 ,recommendations for provider education that can expand patient access to the full range of medication-assisted treatment approved by the ,food and ,drug ,administration for the treatment of opioid addiction and other therapies that manage chronic and acute pain and treat and minimize risk of opioid addiction4 7#e7 ,recommendations for policies under the ,medicare program and under the ,medicaid program that can expand access for rural1 or medically underserved communities to the full range of medication-assisted treatment approved by the ,food and ,drug ,administration for the treatment of opioid addiction and other therapies that manage chronic and acute pain and treatment and minimize risk of opioid addiction4 7c7 ,stakeholder meetings 7#a7 ,in general ,beginning not later than #c months after the date of the enactment of this ,act1 the ,secretary shall convene a public stakeholder meeting to solicit public comment on the components of the action plan recommendations described in subsection 7b74 7#b7 ,participants ,participants of meetings described in paragraph 7#a7 shall include representatives from the ,food and ,drug ,administration and ,national ,institutes of ,health1 biopharmaceutical industry members1 medical researchers1 health care providers1 the medical device industry1 the ,medicare program1 the ,medicaid program1 and patient advocates4 7d7 ,request for information ,not later than #c months after the date of the enactment of this section1 the ,secretary shall issue a request for information seeking public feedback regarding ways in which the ,centers for ,medicare ,medicaid ,services can help address the opioid crisis through the development of and application of the action plan4 7e7 ,report to ,congress ,not later than ,march #a1 #bjai1 the ,secretary shall submit to ,congress1 and make public1 a report that includes a summary of steps taken under the action plan1 recommendations that have emerged under the action plan1 and the ,secretary's planned next steps with respect to the action plan4 7f7 ,definition of ,medication-,assisted treatment ,in this section1 the term medication-assisted treatment includes opioid treatment programs1 behavioral therapy1 and medications to treat substance abuse disorder4 #b4 ,report on coverage1 coding1 and reimbursement policies under ,medicare 7a7 ,in general ,not later than #a year after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services 7in this section referred to as the ,secretary7 shall-- 7#a7 identify-- 7,a7 medical devices that are non-opioid based treatments approved by the ,food and ,drug ,administration for the management of acute pain and chronic pain2 7,b7 medical devices that are non-opioid based treatments approved by the ,food and ,drug ,administration that monitor substance use withdrawal and prevent overdoses of controlled substances2 and 7,c7 medical devices that are non-opioid based treatments approved by the ,food and ,drug ,administration that treat substance use disorder2 and 7#b7 submit to the ,committee on ,finance of the ,senate and the ,committees on ,ways and ,means and ,energy and ,commerce of the ,house of ,representatives1 and publish on a public ,internet website of the ,department of ,health and ,human ,services1 a report containing recommendations on ways to encourage the use of such medical devices by individuals entitled to benefits under part ,a of title ,,xviii of the ,social ,security ,act and enrolled under part ,b of such title 7including individuals enrolled in a ,medicare ,advantage plan under part ,c of such title or in a prescription drug plan under part ,d of such title7 and individuals enrolled under a ,state plan under title ,,xix of such ,act4 7b7 ,contents ,the report under subsection 7a7 shall include an analysis of the following1 with respect to the ,medicare program under title ,,xviii of the ,social ,security ,act and the ,medicaid program under title ,,xix of such ,act3 7#a7 ,various opioid alternatives for pain treatment that are covered under such programs1 that are not covered under such programs1 that have limited coverage under such program1 or with respect to which there are payment barriers under such programs4 7#b7 ,various medical devices that monitor substance use withdrawal and prevent overdose of controlled substances that are covered so covered1 that are not so covered1 that have such limited coverage1 or with respect to which there are such payment barriers4 7#c7 ,various medical devices that treat substance use disorder and opioid use disorder that are so covered1 that are not so covered1 that have such limited coverage1 or with respect to which there are such payment barriers4 7#d7 ,access to payment codes used by health care providers that promote alternative options for pain management therapies without the use of opioids1 including minimally invasive pain therapies4 7#e7 ,ways to improve communications between ,medicare prescription drug plans and ,medicare ,advantage plans1 ,medicare and ,medicaid health care providers1 and ,medicare beneficiaries and ,medicaid beneficiaries on the potential harm associated with the use of opioids and other controlled substances1 including the need to safely store and dispose of supplies relating to the use of opioids and other controlled substances4